Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Research Report 2024(Status and Outlook)
Report Overview:
Nicotinamide mononucleotides play an important role in the energy production of human cells by participating in the intracellular synthesis of NAD (nicotinamide adenine dinucleotide, an important coenzyme in cellular energy conversion). Nicotinamide mononucleotide, which was originally present in the human body but decreases with age. Earlier experiments have shown that nicotinamide mononucleotide NMN increases NAD in the organs of laboratory rats, thus inhibiting ageing of nerves and blood vessels, and also improving the symptoms of diabetes.
The Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size was estimated at USD 527.50 million in 2023 and is projected to reach USD 637.24 million by 2029, exhibiting a CAGR of 3.20% during the forecast period.
This report provides a deep insight into the global Pharmaceutical Grade Nicotinamide Mononucleotide market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmaceutical Grade Nicotinamide Mononucleotide Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmaceutical Grade Nicotinamide Mononucleotide market in any manner.
Global Pharmaceutical Grade Nicotinamide Mononucleotide Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GeneHarbor
Herbalmax
Shinkowa
EffePharm
Mirailab Bioscience
Bangtai Bio
Jindawei
Hongboyuan Life Technology
Market Segmentation (by Type)
Concentration?98%
Concentration?98%
Market Segmentation (by Application)
Health Products
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmaceutical Grade Nicotinamide Mononucleotide Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Nicotinamide mononucleotides play an important role in the energy production of human cells by participating in the intracellular synthesis of NAD (nicotinamide adenine dinucleotide, an important coenzyme in cellular energy conversion). Nicotinamide mononucleotide, which was originally present in the human body but decreases with age. Earlier experiments have shown that nicotinamide mononucleotide NMN increases NAD in the organs of laboratory rats, thus inhibiting ageing of nerves and blood vessels, and also improving the symptoms of diabetes.
The Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size was estimated at USD 527.50 million in 2023 and is projected to reach USD 637.24 million by 2029, exhibiting a CAGR of 3.20% during the forecast period.
This report provides a deep insight into the global Pharmaceutical Grade Nicotinamide Mononucleotide market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmaceutical Grade Nicotinamide Mononucleotide Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmaceutical Grade Nicotinamide Mononucleotide market in any manner.
Global Pharmaceutical Grade Nicotinamide Mononucleotide Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GeneHarbor
Herbalmax
Shinkowa
EffePharm
Mirailab Bioscience
Bangtai Bio
Jindawei
Hongboyuan Life Technology
Market Segmentation (by Type)
Concentration?98%
Concentration?98%
Market Segmentation (by Application)
Health Products
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Pharmaceutical Grade Nicotinamide Mononucleotide Market
- Overview of the regional outlook of the Pharmaceutical Grade Nicotinamide Mononucleotide Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmaceutical Grade Nicotinamide Mononucleotide Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pharmaceutical Grade Nicotinamide Mononucleotide
1.2 Key Market Segments
1.2.1 Pharmaceutical Grade Nicotinamide Mononucleotide Segment by Type
1.2.2 Pharmaceutical Grade Nicotinamide Mononucleotide Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHARMACEUTICAL GRADE NICOTINAMIDE MONONUCLEOTIDE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHARMACEUTICAL GRADE NICOTINAMIDE MONONUCLEOTIDE MARKET COMPETITIVE LANDSCAPE
3.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Manufacturers (2019-2024)
3.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Revenue Market Share by Manufacturers (2019-2024)
3.3 Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pharmaceutical Grade Nicotinamide Mononucleotide Sales Sites, Area Served, Product Type
3.6 Pharmaceutical Grade Nicotinamide Mononucleotide Market Competitive Situation and Trends
3.6.1 Pharmaceutical Grade Nicotinamide Mononucleotide Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharmaceutical Grade Nicotinamide Mononucleotide Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PHARMACEUTICAL GRADE NICOTINAMIDE MONONUCLEOTIDE INDUSTRY CHAIN ANALYSIS
4.1 Pharmaceutical Grade Nicotinamide Mononucleotide Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHARMACEUTICAL GRADE NICOTINAMIDE MONONUCLEOTIDE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PHARMACEUTICAL GRADE NICOTINAMIDE MONONUCLEOTIDE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Type (2019-2024)
6.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Market Share by Type (2019-2024)
6.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Price by Type (2019-2024)
7 PHARMACEUTICAL GRADE NICOTINAMIDE MONONUCLEOTIDE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Sales by Application (2019-2024)
7.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size (M USD) by Application (2019-2024)
7.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Growth Rate by Application (2019-2024)
8 PHARMACEUTICAL GRADE NICOTINAMIDE MONONUCLEOTIDE MARKET SEGMENTATION BY REGION
8.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Region
8.1.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Region
8.1.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Region
8.2 North America
8.2.1 North America Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GeneHarbor
9.1.1 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.1.2 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.1.3 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.1.4 GeneHarbor Business Overview
9.1.5 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide SWOT Analysis
9.1.6 GeneHarbor Recent Developments
9.2 Herbalmax
9.2.1 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.2.2 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.2.3 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.2.4 Herbalmax Business Overview
9.2.5 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide SWOT Analysis
9.2.6 Herbalmax Recent Developments
9.3 Shinkowa
9.3.1 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.3.2 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.3.3 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.3.4 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide SWOT Analysis
9.3.5 Shinkowa Business Overview
9.3.6 Shinkowa Recent Developments
9.4 EffePharm
9.4.1 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.4.2 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.4.3 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.4.4 EffePharm Business Overview
9.4.5 EffePharm Recent Developments
9.5 Mirailab Bioscience
9.5.1 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.5.2 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.5.3 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.5.4 Mirailab Bioscience Business Overview
9.5.5 Mirailab Bioscience Recent Developments
9.6 Bangtai Bio
9.6.1 Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.6.2 Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.6.3 Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.6.4 Bangtai Bio Business Overview
9.6.5 Bangtai Bio Recent Developments
9.7 Jindawei
9.7.1 Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.7.2 Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.7.3 Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.7.4 Jindawei Business Overview
9.7.5 Jindawei Recent Developments
9.8 Hongboyuan Life Technology
9.8.1 Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.8.2 Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.8.3 Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.8.4 Hongboyuan Life Technology Business Overview
9.8.5 Hongboyuan Life Technology Recent Developments
10 PHARMACEUTICAL GRADE NICOTINAMIDE MONONUCLEOTIDE MARKET FORECAST BY REGION
10.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast
10.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Country
10.2.3 Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Region
10.2.4 South America Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pharmaceutical Grade Nicotinamide Mononucleotide by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pharmaceutical Grade Nicotinamide Mononucleotide by Type (2025-2030)
11.1.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pharmaceutical Grade Nicotinamide Mononucleotide by Type (2025-2030)
11.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Forecast by Application (2025-2030)
11.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons) Forecast by Application
11.2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pharmaceutical Grade Nicotinamide Mononucleotide
1.2 Key Market Segments
1.2.1 Pharmaceutical Grade Nicotinamide Mononucleotide Segment by Type
1.2.2 Pharmaceutical Grade Nicotinamide Mononucleotide Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHARMACEUTICAL GRADE NICOTINAMIDE MONONUCLEOTIDE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHARMACEUTICAL GRADE NICOTINAMIDE MONONUCLEOTIDE MARKET COMPETITIVE LANDSCAPE
3.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Manufacturers (2019-2024)
3.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Revenue Market Share by Manufacturers (2019-2024)
3.3 Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pharmaceutical Grade Nicotinamide Mononucleotide Sales Sites, Area Served, Product Type
3.6 Pharmaceutical Grade Nicotinamide Mononucleotide Market Competitive Situation and Trends
3.6.1 Pharmaceutical Grade Nicotinamide Mononucleotide Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharmaceutical Grade Nicotinamide Mononucleotide Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PHARMACEUTICAL GRADE NICOTINAMIDE MONONUCLEOTIDE INDUSTRY CHAIN ANALYSIS
4.1 Pharmaceutical Grade Nicotinamide Mononucleotide Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHARMACEUTICAL GRADE NICOTINAMIDE MONONUCLEOTIDE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PHARMACEUTICAL GRADE NICOTINAMIDE MONONUCLEOTIDE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Type (2019-2024)
6.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Market Share by Type (2019-2024)
6.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Price by Type (2019-2024)
7 PHARMACEUTICAL GRADE NICOTINAMIDE MONONUCLEOTIDE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Sales by Application (2019-2024)
7.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size (M USD) by Application (2019-2024)
7.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Growth Rate by Application (2019-2024)
8 PHARMACEUTICAL GRADE NICOTINAMIDE MONONUCLEOTIDE MARKET SEGMENTATION BY REGION
8.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Region
8.1.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Region
8.1.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Region
8.2 North America
8.2.1 North America Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GeneHarbor
9.1.1 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.1.2 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.1.3 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.1.4 GeneHarbor Business Overview
9.1.5 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide SWOT Analysis
9.1.6 GeneHarbor Recent Developments
9.2 Herbalmax
9.2.1 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.2.2 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.2.3 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.2.4 Herbalmax Business Overview
9.2.5 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide SWOT Analysis
9.2.6 Herbalmax Recent Developments
9.3 Shinkowa
9.3.1 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.3.2 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.3.3 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.3.4 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide SWOT Analysis
9.3.5 Shinkowa Business Overview
9.3.6 Shinkowa Recent Developments
9.4 EffePharm
9.4.1 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.4.2 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.4.3 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.4.4 EffePharm Business Overview
9.4.5 EffePharm Recent Developments
9.5 Mirailab Bioscience
9.5.1 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.5.2 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.5.3 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.5.4 Mirailab Bioscience Business Overview
9.5.5 Mirailab Bioscience Recent Developments
9.6 Bangtai Bio
9.6.1 Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.6.2 Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.6.3 Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.6.4 Bangtai Bio Business Overview
9.6.5 Bangtai Bio Recent Developments
9.7 Jindawei
9.7.1 Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.7.2 Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.7.3 Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.7.4 Jindawei Business Overview
9.7.5 Jindawei Recent Developments
9.8 Hongboyuan Life Technology
9.8.1 Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.8.2 Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.8.3 Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.8.4 Hongboyuan Life Technology Business Overview
9.8.5 Hongboyuan Life Technology Recent Developments
10 PHARMACEUTICAL GRADE NICOTINAMIDE MONONUCLEOTIDE MARKET FORECAST BY REGION
10.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast
10.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Country
10.2.3 Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Region
10.2.4 South America Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pharmaceutical Grade Nicotinamide Mononucleotide by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pharmaceutical Grade Nicotinamide Mononucleotide by Type (2025-2030)
11.1.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pharmaceutical Grade Nicotinamide Mononucleotide by Type (2025-2030)
11.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Forecast by Application (2025-2030)
11.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons) Forecast by Application
11.2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Comparison by Region (M USD)
Table 5. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pharmaceutical Grade Nicotinamide Mononucleotide Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pharmaceutical Grade Nicotinamide Mononucleotide Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Grade Nicotinamide Mononucleotide as of 2022)
Table 10. Global Market Pharmaceutical Grade Nicotinamide Mononucleotide Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pharmaceutical Grade Nicotinamide Mononucleotide Sales Sites and Area Served
Table 12. Manufacturers Pharmaceutical Grade Nicotinamide Mononucleotide Product Type
Table 13. Global Pharmaceutical Grade Nicotinamide Mononucleotide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pharmaceutical Grade Nicotinamide Mononucleotide
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmaceutical Grade Nicotinamide Mononucleotide Market Challenges
Table 22. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Type (Kilotons)
Table 23. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size by Type (M USD)
Table 24. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons) by Type (2019-2024)
Table 25. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Type (2019-2024)
Table 26. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size (M USD) by Type (2019-2024)
Table 27. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Share by Type (2019-2024)
Table 28. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (USD/Ton) by Type (2019-2024)
Table 29. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons) by Application
Table 30. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size by Application
Table 31. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Application (2019-2024)
Table 33. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Application (2019-2024) & (M USD)
Table 34. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Application (2019-2024)
Table 35. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Growth Rate by Application (2019-2024)
Table 36. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Region (2019-2024)
Table 38. North America Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Region (2019-2024) & (Kilotons)
Table 43. GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
Table 44. GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
Table 45. GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GeneHarbor Business Overview
Table 47. GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide SWOT Analysis
Table 48. GeneHarbor Recent Developments
Table 49. Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
Table 50. Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
Table 51. Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Herbalmax Business Overview
Table 53. Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide SWOT Analysis
Table 54. Herbalmax Recent Developments
Table 55. Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
Table 56. Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
Table 57. Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide SWOT Analysis
Table 59. Shinkowa Business Overview
Table 60. Shinkowa Recent Developments
Table 61. EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
Table 62. EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
Table 63. EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. EffePharm Business Overview
Table 65. EffePharm Recent Developments
Table 66. Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
Table 67. Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
Table 68. Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Mirailab Bioscience Business Overview
Table 70. Mirailab Bioscience Recent Developments
Table 71. Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
Table 72. Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
Table 73. Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Bangtai Bio Business Overview
Table 75. Bangtai Bio Recent Developments
Table 76. Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
Table 77. Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
Table 78. Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Jindawei Business Overview
Table 80. Jindawei Recent Developments
Table 81. Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
Table 82. Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
Table 83. Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Hongboyuan Life Technology Business Overview
Table 85. Hongboyuan Life Technology Recent Developments
Table 86. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Forecast by Region (2025-2030) & (Kilotons)
Table 87. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Region (2025-2030) & (M USD)
Table 88. North America Pharmaceutical Grade Nicotinamide Mononucleotide Sales Forecast by Country (2025-2030) & (Kilotons)
Table 89. North America Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Country (2025-2030) & (M USD)
Table 90. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Sales Forecast by Country (2025-2030) & (Kilotons)
Table 91. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Sales Forecast by Region (2025-2030) & (Kilotons)
Table 93. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Region (2025-2030) & (M USD)
Table 94. South America Pharmaceutical Grade Nicotinamide Mononucleotide Sales Forecast by Country (2025-2030) & (Kilotons)
Table 95. South America Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Forecast by Country (2025-2030) & (Units)
Table 97. Middle East and Africa Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Forecast by Type (2025-2030) & (Kilotons)
Table 99. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Type (2025-2030) & (M USD)
Table 100. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price Forecast by Type (2025-2030) & (USD/Ton)
Table 101. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons) Forecast by Application (2025-2030)
Table 102. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Comparison by Region (M USD)
Table 5. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pharmaceutical Grade Nicotinamide Mononucleotide Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pharmaceutical Grade Nicotinamide Mononucleotide Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Grade Nicotinamide Mononucleotide as of 2022)
Table 10. Global Market Pharmaceutical Grade Nicotinamide Mononucleotide Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pharmaceutical Grade Nicotinamide Mononucleotide Sales Sites and Area Served
Table 12. Manufacturers Pharmaceutical Grade Nicotinamide Mononucleotide Product Type
Table 13. Global Pharmaceutical Grade Nicotinamide Mononucleotide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pharmaceutical Grade Nicotinamide Mononucleotide
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmaceutical Grade Nicotinamide Mononucleotide Market Challenges
Table 22. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Type (Kilotons)
Table 23. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size by Type (M USD)
Table 24. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons) by Type (2019-2024)
Table 25. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Type (2019-2024)
Table 26. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size (M USD) by Type (2019-2024)
Table 27. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Share by Type (2019-2024)
Table 28. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (USD/Ton) by Type (2019-2024)
Table 29. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons) by Application
Table 30. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size by Application
Table 31. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Application (2019-2024)
Table 33. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Application (2019-2024) & (M USD)
Table 34. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Application (2019-2024)
Table 35. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Growth Rate by Application (2019-2024)
Table 36. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Region (2019-2024)
Table 38. North America Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Region (2019-2024) & (Kilotons)
Table 43. GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
Table 44. GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
Table 45. GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GeneHarbor Business Overview
Table 47. GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide SWOT Analysis
Table 48. GeneHarbor Recent Developments
Table 49. Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
Table 50. Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
Table 51. Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Herbalmax Business Overview
Table 53. Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide SWOT Analysis
Table 54. Herbalmax Recent Developments
Table 55. Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
Table 56. Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
Table 57. Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide SWOT Analysis
Table 59. Shinkowa Business Overview
Table 60. Shinkowa Recent Developments
Table 61. EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
Table 62. EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
Table 63. EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. EffePharm Business Overview
Table 65. EffePharm Recent Developments
Table 66. Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
Table 67. Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
Table 68. Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Mirailab Bioscience Business Overview
Table 70. Mirailab Bioscience Recent Developments
Table 71. Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
Table 72. Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
Table 73. Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Bangtai Bio Business Overview
Table 75. Bangtai Bio Recent Developments
Table 76. Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
Table 77. Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
Table 78. Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Jindawei Business Overview
Table 80. Jindawei Recent Developments
Table 81. Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
Table 82. Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
Table 83. Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Hongboyuan Life Technology Business Overview
Table 85. Hongboyuan Life Technology Recent Developments
Table 86. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Forecast by Region (2025-2030) & (Kilotons)
Table 87. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Region (2025-2030) & (M USD)
Table 88. North America Pharmaceutical Grade Nicotinamide Mononucleotide Sales Forecast by Country (2025-2030) & (Kilotons)
Table 89. North America Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Country (2025-2030) & (M USD)
Table 90. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Sales Forecast by Country (2025-2030) & (Kilotons)
Table 91. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Sales Forecast by Region (2025-2030) & (Kilotons)
Table 93. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Region (2025-2030) & (M USD)
Table 94. South America Pharmaceutical Grade Nicotinamide Mononucleotide Sales Forecast by Country (2025-2030) & (Kilotons)
Table 95. South America Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Forecast by Country (2025-2030) & (Units)
Table 97. Middle East and Africa Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Forecast by Type (2025-2030) & (Kilotons)
Table 99. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Type (2025-2030) & (M USD)
Table 100. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price Forecast by Type (2025-2030) & (USD/Ton)
Table 101. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons) Forecast by Application (2025-2030)
Table 102. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pharmaceutical Grade Nicotinamide Mononucleotide
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size (M USD), 2019-2030
Figure 5. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size (M USD) (2019-2030)
Figure 6. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmaceutical Grade Nicotinamide Mononucleotide Market Size by Country (M USD)
Figure 11. Pharmaceutical Grade Nicotinamide Mononucleotide Sales Share by Manufacturers in 2023
Figure 12. Global Pharmaceutical Grade Nicotinamide Mononucleotide Revenue Share by Manufacturers in 2023
Figure 13. Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pharmaceutical Grade Nicotinamide Mononucleotide Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pharmaceutical Grade Nicotinamide Mononucleotide Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Type
Figure 18. Sales Market Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Type (2019-2024)
Figure 19. Sales Market Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Type in 2023
Figure 20. Market Size Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Type (2019-2024)
Figure 21. Market Size Market Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Application
Figure 24. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Application (2019-2024)
Figure 25. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Application in 2023
Figure 26. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Application (2019-2024)
Figure 27. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Application in 2023
Figure 28. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Region (2019-2024)
Figure 30. North America Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Country in 2023
Figure 32. U.S. Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Country in 2023
Figure 37. Germany Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Region in 2023
Figure 44. China Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (Kilotons)
Figure 50. South America Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Country in 2023
Figure 51. Brazil Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share Forecast by Type (2025-2030)
Figure 65. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Forecast by Application (2025-2030)
Figure 66. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Pharmaceutical Grade Nicotinamide Mononucleotide
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size (M USD), 2019-2030
Figure 5. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size (M USD) (2019-2030)
Figure 6. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmaceutical Grade Nicotinamide Mononucleotide Market Size by Country (M USD)
Figure 11. Pharmaceutical Grade Nicotinamide Mononucleotide Sales Share by Manufacturers in 2023
Figure 12. Global Pharmaceutical Grade Nicotinamide Mononucleotide Revenue Share by Manufacturers in 2023
Figure 13. Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pharmaceutical Grade Nicotinamide Mononucleotide Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pharmaceutical Grade Nicotinamide Mononucleotide Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Type
Figure 18. Sales Market Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Type (2019-2024)
Figure 19. Sales Market Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Type in 2023
Figure 20. Market Size Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Type (2019-2024)
Figure 21. Market Size Market Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Application
Figure 24. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Application (2019-2024)
Figure 25. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Application in 2023
Figure 26. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Application (2019-2024)
Figure 27. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Application in 2023
Figure 28. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Region (2019-2024)
Figure 30. North America Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Country in 2023
Figure 32. U.S. Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Country in 2023
Figure 37. Germany Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Region in 2023
Figure 44. China Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (Kilotons)
Figure 50. South America Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Country in 2023
Figure 51. Brazil Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share Forecast by Type (2025-2030)
Figure 65. Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Forecast by Application (2025-2030)
Figure 66. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share Forecast by Application (2025-2030)
